Table 1.
Summary of biological effective dose to organs at risk
| Priority | Organ | α/β | BED metric | BED1 | BED1_onCT2 | BED2 | BED sum | Cumulative dose limits | |
|---|---|---|---|---|---|---|---|---|---|
| BED (Gyα/β) | Physical (Gy/4 fx) | ||||||||
| 1 | Spinal canal | 2 | D max (Gy2) | 47.2 | 46.9 | 12.1 | 47.1 | D max < 110.5 | D max < 26 |
| 2 | PBTa | 3 | D max (Gy3) | 21.8 | 21.5 | 32.2 | 34.7 | D max < 135.7 | D max < 34.8 |
| 3 | Esophagus | 3 | D max (Gy3) | 100.5 | 104.3 | 12.7 | 104.4 | D max < 105 | D max < 30 |
| 4 | Lungs‐PTVb | 3 | V 53.3Gy3 (%) | 3.5 | 1.8 | 1.3 | 3.3 | V 53.3 < 10% | V20 < 10% |
| 5 | Heart | 3 | D max (Gy3) | 104.6 | 107.8 | 40.5 | 107.9 | D max < 130.3 | D max < 34 |
| 6 | Skin | 3 | D max (Gy3) | 47.3 | 48.5 | 99.5 | 105.0 | D max < 144 | D max < 36 |
BED1 doses are reported using CT1 contours.
BED1_onCT2 doses are reported using CT2 contours after warping BED1 onto CT2.
BED2 and BED sum doses are reported using CT2 contours.
PBT, proximal bronchial tree.
Lungs‐PTV contours are different in CT1 and CT2 due to different PTVs.